In the BioHarmony Drug Report Database
Idarubicin
Idamycin, Idamycin Pfs (idarubicin) is a small molecule pharmaceutical. Idarubicin was first approved as Idamycin on 1990-09-27. It is used to treat bcr-abl positive chronic myelogenous leukemia, breast neoplasms, myeloid leukemia acute, and precursor cell lymphoblastic leukemia-lymphoma in the USA.
Trade Name
|
Idamycin, Idamycin Pfs |
|---|---|
Common Name
|
idarubicin |
ChEMBL ID
|
CHEMBL1117 |
Indication
|
bcr-abl positive chronic myelogenous leukemia, breast neoplasms, myeloid leukemia acute, precursor cell lymphoblastic leukemia-lymphoma |
Drug Class
|
Antineoplastic antibiotics (daunorubicin type) |
Image (chem structure or protein)